Coretech 5

Equities

MLCOT

FR0013371507

Real-time Euronext Paris Other stock markets 05:30:16 2024-05-17 EDT			5-day change	1st Jan Change
0.02 ^EUR	-55.56%		-55.56%	+300.00%

2023	Gour Medical SA announced that it has received â‚¬0.135 million in funding	CI
2023	Gour Medical SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Gour Medical : Annonce légale

June 14, 2023 at 10:18 am

Annonce légale

14 Jun 2023 16:12 CEST

Issuer

GOUR MEDICAL

ap-14062023-1.pdf

Source

GOUR MEDICAL S.A.

Provider

Euronext

Company Name

GOUR MEDICAL

ISIN

FR0013371507

Symbol

MLGML

Market

Euronext Access

Attachments

Original Link
Original Document
Permalink

Disclaimer

Gour Medical SA published this content on 14 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2023 14:17:00 UTC.

Latest news about Coretech 5

Gour Medical SA announced that it has received â‚¬0.135 million in funding	23-07-09	CI
Gour Medical SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-06-07	CI
Gour Medical SA cancelled its agreement to acquire Worldwide Rights to a dual orexin receptor antagonist from Actelion Pharmaceuticals Ltd.	16-03-09	CI
Actelion Pharmaceuticals Ltd entered into a definitive worldwide license agreement to acquire Worldwide Rights to a dual orexin receptor antagonist from Gour Medical SA.	15-03-09	CI

Chart Coretech 5

Duration

Period

More charts

Company Profile

Coretech 5 (formerly Gour Medical) specializes in the development and commercialization of innovative veterinary solutions for the management of the main pathologies of companion animals. Its unique positioning is based in particular on the use of natural products based on hemp extracts. Devoid of psychoactive effects, WEEDLEY, its first range of premium solutions, increases the effectiveness of cannabidiol thanks to the surround effect.

Sector

More about the company

Income Statement Evolution

More financial data